Showing 1171-1180 of 1402 results for "".
- Lensar Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrellhttps://modernod.com/news/lensar-expands-board-of-directors-with-the-appointments-of-aimee-s-weisner-and-elizabeth-g-ofarrell/2478817/Lensar announced the expansion of its board of directors to seven members with the appointments of Aimee S. Weisner and Elizabeth G. O’Farrell, effective February 1, 2021. In addition to serving on the company’s Board of Directors, Ms. Weisner will
- DORC Announces FDA Acceptance of Orphan NDA for Brilliant Blue G Ophthalmic Solutionhttps://modernod.com/news/dorc-announces-fda-acceptance-of-orphan-nda-for-brilliant-blue-g-ophthalmic-solution/2476701/DORC has announced that it has received notification from the FDA that their new drug application (NDA) for Brilliant Blue G ophthalmic solution has been accepted for review. The proposed indication for Brillia
- Opthea Names Quinton Oswald and Susan Orr, OD, to its Board of Directorshttps://modernod.com/news/opthea-names-quinton-oswald-and-susan-orr-od-to-its-board-of-directors/2480790/Opthea announced the appointment of Quinton Oswald and Susan Orr, OD, to its Board of Directors, effective immediately following election at a General Meeting of Shareholders on April 21st, 2022. Mr. Oswald and Dr. Orr have deep experience leading biotech companies and launching c
- OD-OS Introduces Teleguidance Software for Navilas 577s Navigated Retina Laserhttps://modernod.com/news/od-os-introduces-teleguidance-software-for-navilas-577s-navigated-retina-laser/2479491/OD-OS has launched additional remote access capabilities for its Navilas Laser System 577s to address common challenges in ophthalmology that were enhanced during the COVID-19 pandemic. The new teleguidance capabilities give doctors remote access to the device to pre-plan a retinal laser treatmen
- OD-OS to Showcase Navilas Navigated Retinal Laser Therapy at EURETINAhttps://modernod.com/news/od-os-to-showcase-navilas-navigated-retinal-laser-therapy-at-euretina/2476852/OD-OS will share clinical experiences with the Navilas 577s digital treatment platform this week at the EURETINA Congress in Paris. Navigated retinal laser therapy with the Navilas 577s allows for panretinal photocoagulation with uniform spot distribution, which is faster and less painful for pat
- New Software Update Expands Capabilities of the OD-OS Navilas 577shttps://modernod.com/news/new-software-update-expands-capabilities-of-the-od-os-navilas-577s/2476754/OD-OS has released a new software update for its Navilas 577s. With a new multimodal “export wizard,” retina specialists can generate high resolution images of their treatments in different configurations. This allows for advanced, transparent documentation for all purposes and record
- SECO International Names J. Max Ernst, OD, as 2020 Presidenthttps://modernod.com/news/seco-international-names-j-max-ernst-od-as-2020-president/2476329/SECO International, the world’s largest educational conference, has announced that J. Max Ernst, OD, will become the next SECO International President. Dr. Ernst will officially accept the honor during the House of Delegates meeting, held during SECO 2019, Saturday, February 23, from 3:15 pm-5 pm
- OD-OS Releases Intuitive Iridotomy Treatment with the Navilas 577s Retina Laserhttps://modernod.com/news/od-os-releases-intuitive-iridotomy-treatment-with-the-navilas-577s-retina-laser/2479613/OD-OS has released a software update for its Navilas 577s retinal laser system (version 3.5) that incorporates a new intuitive anterior segment treatment mode for Laser Peripheral Iridotomy (LPI). The new LPI treatment mode supports the therapy of narrow-angle glaucoma and thus can contribute to
- ScienceBased Health Welcomes New Members to Its Optometry Clinical Advisory Panelhttps://modernod.com/news/sciencebased-health-welcomes-new-members-to-its-optometry-clinical-advisory-panel/2481787/ScienceBased Health (SBH) announced the addition of Jaclyn Garlich, OD, FAAO; Jacob Lang, OD, FAAO, Dipl ABO; and Mark Schaeffer, OD to its Optometry Clinical Advisory Panel. ScienceBased Health develops and markets e
- Amring Pharmaceuticals Names Jai G. Parekh, MD, Chief Commercial Officer, Eye Care, UShttps://modernod.com/news/amring-pharmaceuticals-names-jai-g-parekh-md-chief-commercial-officer-eye-care-us/2482059/Amring Pharmaceuticals, a subsidiary of Nordic Group BV, has named Jai G. Parekh, MD, MBA, as Chief Commercial Officer, Eye Care, US. Nordic Pharma recently expanded its pharmaceutical presence in the US by acquiring Visant Medical, maker of the FDA-c